Patient navigation may aid in breast cancer treatment in high-risk populations

Patient navigation, or the linking of a newly diagnosed cancer patient with a professional trained in assisting patients though the complex journey of cancer diagnosis and treatment, may lead to better breast cancer care in high risk and minority women. The findings, recently published in the Journal of Clinical Oncology, is the first national study to show a relationship between navigators and the initiation of certain recommended treatments in breast cancer.

Using data from a previously published, multi-center study funded by the National Cancer Institute, researchers aimed to identify the possible benefits of assigning patient navigators to women recently diagnosed with . According to the results, women were more likely to start recommended treatment when assisted by one of these trained specialists. For example, they were more likely to start hormonal therapy, which is considered the gold standard in treatment for certain types of breast cancer.

Naomi Ko, MD, MPH, instructor of medicine in the Section of Hematology Oncology at Boston University School of Medicine and a practicing breast oncologist at Boston Medical Center, stresses the need for further investigation. "This study gave us a glimpse of the potential benefit of patient navigation but there's a lot more research to be done. At this point we still need to understand how or why patient navigation works. Understanding where patient navigation is most beneficial in cancer care, in order to help the neediest patients, is a rich topic for future research," said Ko.

Navigators are experts in helping patients overcome the numerous obstacles they face, including monetary difficulties, transportation issues, educational and even language barriers, and have become an integral part of the model. It has been known that minority and patients, or those who may benefit most from these navigators, often have worse outcomes after diagnosed with cancer.

Related Stories

Men develop breast cancer, too

date Jul 08, 2014

(HealthDay)—While rare, breast cancer does occur in men and is often diagnosed at a later age and stage than in women, experts say.

Recommended for you

Merck drug Keytruda effective against 3 cancers

date 4 hours ago

One of the hot new cancer immunotherapy drugs, Merck & Co.'s Keytruda, strongly benefited patients with melanoma, lung cancer and mesothelioma, according to three studies presented Sunday at the American Association for Cancer ...

DNA blood test detects lung cancer mutations

date Apr 17, 2015

Cancer DNA circulating in the bloodstream of lung cancer patients can provide doctors with vital mutation information that can help optimise treatment when tumour tissue is not available, an international group of researchers ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.